A review of complementary and alternative treatments for autism spectrum disorders.

Psychopharmacological prescriptions for people with autism spectrum disorder (ASD): a multinational study. Psychopharmacology (Berl) (2013) 1.47

Redox metabolism abnormalities in autistic children associated with mitochondrial disease. Transl Psychiatry (2013) 1.00

Biomarkers in autism. Front Psychiatry (2014) 0.92

Internet-based, randomized, controlled trial of omega-3 fatty acids for hyperactivity in autism. J Am Acad Child Adolesc Psychiatry (2014) 0.89

A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel. Front Public Health (2013) 0.88

Treatment of tactile impairment in young children with autism: results with qigong massage. Int J Ther Massage Bodywork (2013) 0.86

Effectiveness of methylcobalamin and folinic Acid treatment on adaptive behavior in children with autistic disorder is related to glutathione redox status. Autism Res Treat (2013) 0.86

Prevalence and correlates of use of complementary and alternative medicine in children with autism spectrum disorder in Europe. Eur J Pediatr (2015) 0.79

Zen shiatsu: a longitudinal case study measuring stress reduction in a child with autism spectrum disorder. Int J Ther Massage Bodywork (2014) 0.77

Music therapy: An effective approach in improving social skills of children with autism. Adv Biomed Res (2015) 0.75

Neurofeedback learning modifies the incidence rate of alpha spindles, but not their duration and amplitude. Sci Rep (2017) 0.75

A Randomized, Placebo-controlled Trial of Digestive Enzymes in Children with Autism Spectrum Disorders. Clin Psychopharmacol Neurosci (2015) 0.75

Herbal Medicine Treatment for Children with Autism Spectrum Disorder: A Systematic Review. Evid Based Complement Alternat Med (2017) 0.75

The epidemiology of autism spectrum disorders. Annu Rev Public Health (2007) 4.52

Management of children with autism spectrum disorders. Pediatrics (2007) 3.62

Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry (2005) 3.36

Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry (1996) 3.05

Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry (2006) 3.01

Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr (2004) 3.00

Omega-3 fatty acids supplementation for autism spectrum disorders (ASD). Cochrane Database Syst Rev (2011) 2.29

Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Biol Psychiatry (2006) 2.17

Gastrointestinal flora and gastrointestinal status in children with autism--comparisons to typical children and correlation with autism severity. BMC Gastroenterol (2011) 2.10

Efficacy of sensory and motor interventions for children with autism. J Autism Dev Disord (2002) 1.99

Melatonin in autism spectrum disorders: a systematic review and meta-analysis. Dev Med Child Neurol (2011) 1.94

Melatonin versus placebo in children with autism spectrum conditions and severe sleep problems not amenable to behaviour management strategies: a randomised controlled crossover trial. J Autism Dev Disord (2011) 1.66

Autism spectrum disorders: early detection, intervention, education, and psychopharmacological management. Can J Psychiatry (2003) 1.61

A systematic review of secretin for children with autism spectrum disorders. Pediatrics (2011) 1.60

Behavioral effects of omega-3 fatty acid supplementation in young adults with severe autism: an open label study. Arch Med Res (2008) 1.59

A randomized controlled pilot trial of oral N-acetylcysteine in children with autism. Biol Psychiatry (2012) 1.58

Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity. Nutr Metab (Lond) (2011) 1.58

The effects of aerobic exercise on academic engagement in young children with autism spectrum disorder. Pediatr Phys Ther (2011) 1.55

High-dose pyridoxine and magnesium administration in children with autistic disorder: an absence of salutary effects in a double-blind, placebo-controlled study. J Autism Dev Disord (1997) 1.51

Randomized controlled trial of electro-acupuncture for autism spectrum disorder. Altern Med Rev (2010) 1.50

Efficacy of vitamin B6 and magnesium in the treatment of autism: a methodology review and summary of outcomes. J Autism Dev Disord (1995) 1.49

Randomized controlled trial of acupuncture versus sham acupuncture in autism spectrum disorder. J Altern Complement Med (2010) 1.47

The gluten-free, casein-free diet in autism: an overview with clinical implications. Nutr Clin Pract (2008) 1.46

Effects of Thai traditional massage on autistic children's behavior. J Altern Complement Med (2009) 1.44

Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism. Am J Clin Nutr (2008) 1.42

The effect of therapeutic horseback riding on social functioning in children with autism. J Autism Dev Disord (2009) 1.41

Animal-assisted therapy for children with pervasive developmental disorders. West J Nurs Res (2002) 1.38

Intensive behavioral/psychoeducational treatments for autism: research needs and future directions. J Autism Dev Disord (2000) 1.37

The influence of vigorous versus mild exercise on autistic stereotyped behaviors. J Autism Dev Disord (1984) 1.35

The ScanBrit randomised, controlled, single-blind study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders. Nutr Neurosci (2010) 1.31

The immune system's role in the biology of autism. Curr Opin Neurol (2010) 1.31

Patterns of complementary and alternative medical therapy use in children diagnosed with autism spectrum disorders. J Autism Dev Disord (2006) 1.30

Use of complementary and alternative medicine among children recently diagnosed with autistic spectrum disorder. J Dev Behav Pediatr (2003) 1.29

The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome, or autism and fragile X syndrome. J Clin Sleep Med (2009) 1.25

Use of complementary and alternative medicine among children diagnosed with autism spectrum disorder. J Autism Dev Disord (2007) 1.24

Music therapy for autistic spectrum disorder. Cochrane Database Syst Rev (2006) 1.23

Plasma fatty acid levels in autistic children. Prostaglandins Leukot Essent Fatty Acids (2001) 1.20

Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems. Child Care Health Dev (2006) 1.15

Pilot study of a moderate dose multivitamin/mineral supplement for children with autistic spectrum disorder. J Altern Complement Med (2004) 1.15

Essential fatty acids and phospholipase A2 in autistic spectrum disorders. Prostaglandins Leukot Essent Fatty Acids (2004) 1.15

A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities. J Pineal Res (2008) 1.14

The effect of high doses of vitamin B6 on autistic children: a double-blind crossover study. Am J Psychiatry (1978) 1.13

Novel and emerging treatments for autism spectrum disorders: a systematic review. Ann Clin Psychiatry (2009) 1.12

Parental perceptions and use of complementary and alternative medicine practices for children with autistic spectrum disorders in private practice. J Dev Behav Pediatr (2006) 1.12

Implementing a research agenda for complementary and alternative medicine. Annu Rev Med (2004) 1.12

Sleep dysfunction in Rett syndrome: a trial of exogenous melatonin treatment. Dev Med Child Neurol (1998) 1.12

Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part A--medical results. BMC Clin Pharmacol (2009) 1.11

Decreasing self-stimulatory behavior with physical exercise in a group of autistic boys. J Autism Dev Disord (1980) 1.08

Pharmacologic treatment of behavioral symptoms in autism and pervasive developmental disorders. J Clin Psychiatry (2005) 1.07

Complementary and alternative medical therapies for attention-deficit/hyperactivity disorder and autism. Pediatr Clin North Am (2007) 1.06

A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder. J Autism Dev Disord (2011) 1.06

Neurofeedback for autistic spectrum disorder: a review of the literature. Appl Psychophysiol Biofeedback (2010) 1.05

Effect of a vitamin/mineral supplement on children and adults with autism. BMC Pediatr (2011) 1.05

Gluten- and casein-free diets for autistic spectrum disorder. Cochrane Database Syst Rev (2008) 1.04

Music therapy in the assessment and treatment of autistic spectrum disorder: clinical application and research evidence. Child Care Health Dev (2006) 1.03

Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders. J Child Neurol (2002) 1.03

The effects of improvisational music therapy on joint attention behaviors in autistic children: a randomized controlled study. J Autism Dev Disord (2008) 1.03

Treatment incidence and patterns in children and adolescents with autism spectrum disorders. J Child Adolesc Psychopharmacol (2005) 1.02

Emotional, motivational and interpersonal responsiveness of children with autism in improvisational music therapy. Autism (2009) 1.01

Complementary and alternative medicine treatments for children with autism spectrum disorders. Child Adolesc Psychiatr Clin N Am (2008) 1.01

Omega 3 fatty acid treatment in autism. J Child Adolesc Psychopharmacol (2009) 1.00

The differential and temporal effects of antecedent exercise on the self-stimulatory behavior of a child with autism. Res Dev Disabil (1997) 1.00

Role of polyunsaturated fatty acids in the management of Egyptian children with autism. Clin Biochem (2008) 0.99

Occupational therapy incorporating animals for children with autism: A pilot investigation. Am J Occup Ther (2006) 0.99

Brief report: improvements in the behavior of children with autism following massage therapy. J Autism Dev Disord (2001) 0.98

A preliminary trial of ascorbic acid as supplemental therapy for autism. Prog Neuropsychopharmacol Biol Psychiatry (1993) 0.98

Use of complementary and alternative treatments for children with autistic spectrum disorders is increasing. Pediatr Ann (2003) 0.97

Brief report: autistic children's attentiveness and responsivity improve after touch therapy. J Autism Dev Disord (1997) 0.97

Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part B - behavioral results. BMC Clin Pharmacol (2009) 0.97

Massage therapy for children with autism spectrum disorders: a systematic review. J Clin Psychiatry (2010) 0.97

Qigong massage treatment for sensory and self-regulation problems in young children with autism: a randomized controlled trial. Am J Occup Ther (2009) 0.95

Vigorous, aerobic exercise versus general motor training activities: effects on maladaptive and stereotypic behaviors of adults with both autism and mental retardation. J Autism Dev Disord (1994) 0.95

Introduction: novel therapies in developmental disabilities--hope, reason, and evidence. Ment Retard Dev Disabil Res Rev (2005) 0.94

Scientifically unsupported therapies in the treatment of young children with autism spectrum disorders. Pediatr Ann (2007) 0.94

Micronutrients versus standard medication management in autism: a naturalistic case-control study. J Child Adolesc Psychopharmacol (2010) 0.93

Children with autism: effect of iron supplementation on sleep and ferritin. Pediatr Neurol (2007) 0.93

Ferritin and iron levels in children with autistic disorder. Eur J Pediatr (2011) 0.92

Acupuncture for autism spectrum disorders (ASD). Cochrane Database Syst Rev (2011) 0.92

Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6. II. Pervasive developmental disorder-autism. Magnes Res (2006) 0.92

Improvement in sensory impairment and social interaction in young children with autism following treatment with an original Qigong massage methodology. Am J Chin Med (2007) 0.91

Brief report: the effects of exercise on the self-stimulatory behaviors and positive responding of adolescents with autism. J Autism Dev Disord (1997) 0.90

Management of symptoms in children with autism spectrum disorders: a comprehensive review of pharmacologic and complementary-alternative medicine treatments. J Dev Behav Pediatr (2011) 0.90

Complementary and alternative medicine in autism: an evidence-based approach to negotiating safe and efficacious interventions with families. Neurotherapeutics (2010) 0.90

Combined vitamin B6-magnesium treatment in autism spectrum disorder. Cochrane Database Syst Rev (2005) 0.89

Use of complementary and alternative medicine (CAM) in autism spectrum disorder (ASD): comparison of Chinese and western culture (Part A). J Autism Dev Disord (2008) 0.89

Treatment of children with autism with intravenous immunoglobulin. J Child Neurol (1999) 0.88

Pilot study of the effect of methyl B12 treatment on behavioral and biomarker measures in children with autism. J Altern Complement Med (2010) 0.86

Epidemiology and management of insomnia in children with autistic spectrum disorders. Paediatr Drugs (2010) 0.86

Functional neuroanatomy and the rationale for using EEG biofeedback for clients with Asperger's syndrome. Appl Psychophysiol Biofeedback (2009) 0.85

Digestive enzyme supplementation for autism spectrum disorders: a double-blind randomized controlled trial. J Autism Dev Disord (2010) 0.85

Medical treatment overview: traditional and novel psycho-pharmacological and complementary and alternative medications. Curr Opin Pediatr (2011) 0.85

Scalp acupuncture effect on language development in children with autism: a pilot study. J Altern Complement Med (2008) 0.85

Acupuncture for treatment of autism spectrum disorders. Evid Based Complement Alternat Med (2011) 0.84

Parents' views and experiences about complementary and alternative medicine treatments for their children with autistic spectrum disorder. J Autism Dev Disord (2010) 0.82

Controlled evaluation of the effects of hyperbaric oxygen therapy on the behavior of 16 children with autism spectrum disorders. J Autism Dev Disord (2011) 0.82

Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial. J Clin Pharm Ther (2004) 0.81

Auditory integration training and other sound therapies for autism spectrum disorders. Cochrane Database Syst Rev (2004) 0.80

Neurofeedback in autism spectrum disorders. Dev Med Child Neurol (2011) 0.80

Effects of pyridoxine and magnesium on autistic symptoms--initial observations. J Autism Dev Disord (1981) 0.79

Vitamin B6, magnesium, and combined B6-Mg: therapeutic effects in childhood autism. Biol Psychiatry (1985) 0.78

Risperidone in children with autism and serious behavioral problems. N Engl J Med (2002) 9.35

The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry (2009) 6.71

Geographic variation in the prevalence of attention-deficit/hyperactivity disorder: the sunny perspective. Biol Psychiatry (2013) 3.47

3-year follow-up of the NIMH MTA study. J Am Acad Child Adolesc Psychiatry (2007) 3.33

Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. Am J Psychiatry (2005) 2.94

Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment. J Am Acad Child Adolesc Psychiatry (2009) 2.13

Resting-state functional connectivity of subgenual anterior cingulate cortex in depressed adolescents. Biol Psychiatry (2013) 2.07

Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. J Am Acad Child Adolesc Psychiatry (2007) 2.03

What aspects of peer relationships are impaired in children with attention-deficit/hyperactivity disorder? J Consult Clin Psychol (2005) 2.03

Which treatment for whom for ADHD? Moderators of treatment response in the MTA. J Consult Clin Psychol (2003) 2.02

Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning. J Abnorm Child Psychol (2007) 1.98

Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects. J Am Acad Child Adolesc Psychiatry (2007) 1.98

Risperidone and adaptive behavior in children with autism. J Am Acad Child Adolesc Psychiatry (2006) 1.71

A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorder. J Clin Psychiatry (2008) 1.70

A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Med (2012) 1.67

Characteristics of children with elevated symptoms of mania: the Longitudinal Assessment of Manic Symptoms (LAMS) study. J Clin Psychiatry (2010) 1.67

Validity of the autism diagnostic interview-revised. Am J Ment Retard (2006) 1.66

The services for children and adolescents-parent interview: development and performance characteristics. J Am Acad Child Adolesc Psychiatry (2004) 1.64

Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry (2006) 1.61

Examining executive functioning in children with autism spectrum disorder, attention deficit hyperactivity disorder and typical development. Psychiatry Res (2009) 1.56

Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial. J Am Acad Child Adolesc Psychiatry (2009) 1.55

Increasing knowledge of PTEN germline mutations: Two additional patients with autism and macrocephaly. Am J Med Genet A (2007) 1.52

Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses. J Am Acad Child Adolesc Psychiatry (2007) 1.48

Longitudinal Assessment of Manic Symptoms (LAMS) study: background, design, and initial screening results. J Clin Psychiatry (2010) 1.47

Gastrointestinal symptoms in a sample of children with pervasive developmental disorders. J Autism Dev Disord (2008) 1.46

Self-perceptions of competence in children with ADHD and comparison children. J Consult Clin Psychol (2004) 1.43

Peer-assessed outcomes in the multimodal treatment study of children with attention deficit hyperactivity disorder. J Clin Child Adolesc Psychol (2005) 1.41

Neurochemical correlates of autistic disorder: a review of the literature. Res Dev Disabil (2005) 1.38

Assessing medication effects in the MTA study using neuropsychological outcomes. J Child Psychol Psychiatry (2006) 1.34

Parent-reported homework problems in the MTA study: evidence for sustained improvement with behavioral treatment. J Clin Child Adolesc Psychol (2010) 1.31

Reliability of the services for children and adolescents-parent interview. J Am Acad Child Adolesc Psychiatry (2004) 1.31

Assessing Homework Problems in Children with ADHD: Validation of a Parent-Report Measure and Evaluation of Homework Performance Patterns. School Ment Health (2010) 1.27

Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: executive summary. J Atten Disord (2008) 1.27

Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD. Am J Psychiatry (2005) 1.26

Acute and long-term safety and tolerability of risperidone in children with autism. J Child Adolesc Psychopharmacol (2005) 1.24

The transition to middle school is associated with changes in the developmental trajectory of ADHD symptomatology in young adolescents with ADHD. J Clin Child Adolesc Psychol (2008) 1.24

Examining the proposed disruptive mood dysregulation disorder diagnosis in children in the Longitudinal Assessment of Manic Symptoms study. J Clin Psychiatry (2012) 1.23

Socioeconomic status as a moderator of ADHD treatment outcomes. J Am Acad Child Adolesc Psychiatry (2002) 1.23

Methylphenidate treatment in children with borderline IQ and mental retardation: analysis of three aggregated studies. J Child Adolesc Psychopharmacol (2003) 1.23

Patterns and predictors of adolescent academic achievement and performance in a sample of children with attention-deficit/hyperactivity disorder. J Clin Child Adolesc Psychol (2011) 1.20

Effects of short- and long-term risperidone treatment on prolactin levels in children with autism. Biol Psychiatry (2006) 1.18

Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of children with ADHD (MTA): Part II: supporting details. J Atten Disord (2008) 1.18

Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD. Am J Psychiatry (2012) 1.18

Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms. J Am Acad Child Adolesc Psychiatry (2005) 1.17

Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data. Am J Psychiatry (2004) 1.16

Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial. J Child Adolesc Psychopharmacol (2003) 1.15

Peer rejection and friendships in children with Attention-Deficit/Hyperactivity Disorder: contributions to long-term outcomes. J Abnorm Child Psychol (2012) 1.13

EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors. Lipids (2003) 1.12

Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome. Schizophr Res (2010) 1.11

Time-dependent changes in positively biased self-perceptions of children with attention-deficit/hyperactivity disorder: a developmental psychopathology perspective. Dev Psychopathol (2010) 1.08

The treatment of severe child aggression (TOSCA) study: Design challenges. Child Adolesc Psychiatry Ment Health (2011) 1.05

Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems. J Am Acad Child Adolesc Psychiatry (2011) 1.05

A review of neurofeedback treatment for pediatric ADHD. J Atten Disord (2011) 1.03

Feasibility of a nutritional supplement as treatment for pediatric bipolar spectrum disorders. J Altern Complement Med (2012) 1.03

Artificial food colors and attention-deficit/hyperactivity symptoms: conclusions to dye for. Neurotherapeutics (2012) 1.01

Developmental processes in peer problems of children with attention-deficit/hyperactivity disorder in the Multimodal Treatment Study of Children With ADHD: developmental cascades and vicious cycles. Dev Psychopathol (2010) 1.00

Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures. Biol Psychiatry (2007) 1.00

Dietary sensitivities and ADHD symptoms: thirty-five years of research. Clin Pediatr (Phila) (2010) 0.99

The role of children's ethnicity in the relationship between teacher ratings of attention-deficit/hyperactivity disorder and observed classroom behavior. J Consult Clin Psychol (2005) 0.99

Examining predictors of reaction times in children with ADHD and normal controls. J Int Neuropsychol Soc (2009) 0.98

EEG neurofeedback for ADHD: double-blind sham-controlled randomized pilot feasibility trial. J Atten Disord (2012) 0.97

Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit/hyperactivity disorder. J Consult Clin Psychol (2006) 0.96

A clinical review of outcomes of the multimodal treatment study of children with attention-deficit/hyperactivity disorder (MTA). Curr Psychiatry Rep (2008) 0.96

Trial design challenges when combining medication and parent training in children with pervasive developmental disorders. J Autism Dev Disord (2008) 0.96

Treatment for ADHD: is more complex treatment cost-effective for more complex cases? Health Serv Res (2007) 0.96

Psychopharmacological and other treatments in preschool children with attention-deficit/hyperactivity disorder: current evidence and practice. J Child Adolesc Psychopharmacol (2008) 0.96

Age at first autism spectrum disorder diagnosis: the role of birth cohort, demographic factors, and clinical features. J Dev Behav Pediatr (2014) 0.96

Parental Agreement on ADHD Symptom-Specific and Broadband Externalizing Ratings of Child Behavior. J Emot Behav Disord (2010) 0.95

Serum ferritin and amphetamine response in youth with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol (2010) 0.94

Examination of aggression and self-injury in children with autism spectrum disorders and serious behavioral problems. Child Adolesc Psychiatr Clin N Am (2014) 0.94

A prospective open trial of guanfacine in children with pervasive developmental disorders. J Child Adolesc Psychopharmacol (2006) 0.94

Bipolar and ADHD Comorbidity: Both Artifact and Outgrowth of Shared Mechanisms. Clin Psychol (New York) (2010) 0.94

Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity. J Autism Dev Disord (2008) 0.94

Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders. Child Adolesc Psychiatr Clin N Am (2008) 0.94

Effects of once-daily oral and transdermal methylphenidate on sleep behavior of children with ADHD. J Atten Disord (2008) 0.93

Multinutrient supplement as treatment: literature review and case report of a 12-year-old boy with bipolar disorder. J Child Adolesc Psychopharmacol (2009) 0.92

Research Units of Pediatric Psychopharmacology (RUPP) autism network randomized clinical trial of parent training and medication: one-year follow-up. J Am Acad Child Adolesc Psychiatry (2012) 0.90

Research knowledge among parents of children participating in a randomized clinical trial. J Am Acad Child Adolesc Psychiatry (2005) 0.89

High concordance of parent and teacher attention-deficit/hyperactivity disorder ratings in medicated and unmedicated children with autism spectrum disorders. J Child Adolesc Psychopharmacol (2012) 0.89

Relation between outcomes on a continuous performance test and ADHD symptoms over time. J Abnorm Child Psychol (2011) 0.88

Parent satisfaction in a multi-site acute trial of risperidone in children with autism: a social validity study. Psychopharmacology (Berl) (2006) 0.88

Does switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life and medication satisfaction for children with attention-deficit/hyperactivity disorder? Child Adolesc Psychiatry Ment Health (2009) 0.88

Current status of neurofeedback for attention-deficit/hyperactivity disorder. Curr Psychiatry Rep (2012) 0.87

Developmental disabilities modification of the Children's Global Assessment Scale. Biol Psychiatry (2007) 0.86

What differentiates children visiting outpatient mental health services with bipolar spectrum disorder from children with other psychiatric diagnoses? Bipolar Disord (2012) 0.86

Maternal depressive symptomatology and parenting behavior: exploration of possible mediators. J Abnorm Child Psychol (2007) 0.86

A study on the effectiveness of videoconferencing on teaching parent training skills to parents of children with ADHD. Telemed J E Health (2013) 0.86

Cognitive effects of risperidone in children with autism and irritable behavior. J Child Adolesc Psychopharmacol (2008) 0.86

Empirical evaluation of the generalizability of the sample from the multimodal treatment study for ADHD. Adm Policy Ment Health (2006) 0.86

Phenomenology of bipolar disorder not otherwise specified in youth: a comparison of clinical characteristics across the spectrum of manic symptoms. Bipolar Disord (2013) 0.86

Impact of ADHD and cannabis use on executive functioning in young adults. Drug Alcohol Depend (2013) 0.86

Clinical characteristics of children receiving antipsychotic medication. J Child Adolesc Psychopharmacol (2011) 0.86

Parents' perceptions of benefit of children's mental health treatment and continued use of services. Psychiatr Serv (2012) 0.85

Mental health service use by children with serious emotional and behavioral disturbance: results from the LAMS study. Psychiatr Serv (2011) 0.84